Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?

20 Nov 2023

Abstract excerpt

Intestinal bacteria are equipped with an enzyme apparatus that is involved in the active biotransformation of xenobiotics, including drugs. Pharmacomicrobiomics, a new area of pharmacology, analyses interactions between bacteria and xenobiotics. However, there is another side to the coin. Pharmacotherapeutic agents can significantly modify the microbiota, which consequently affects their efficacy. In this review,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37985748
DOI: 10.1080/19490976.2023.2281017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?PMID 37985748Read ↗

Gut Microbiota Shapes the Efficiency of Cancer TherapySemantic proximity Read ↗

Is There an Interplay between Environmental Factors, Microbiota Imbalance, and Cancer Chemotherapy-Associated Intestinal Mucositis?Semantic proximity Read ↗

Towards a mechanistic understanding of reciprocal drug–microbiome interactionsSemantic proximity Read ↗

Mechanisms of gastrointestinal microflora on drug metabolism in clinical practiceSemantic proximity Read ↗

A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer TherapySemantic proximity Read ↗

Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug–microbiome interactionsSemantic proximity Read ↗

Microbes and Cancer: Friends or Faux?Semantic proximity Read ↗

Catalog of gut microbiota alterations associated with anticancer therapies across multiple cancer typesSemantic proximity Read ↗

How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?Semantic proximity Read ↗

Therapeutic Modulation of the Microbiome in Oncology: Current Trends and Future DirectionsSemantic proximity Read ↗

The influence of gut microbiota on drug metabolism and toxicitySemantic proximity Read ↗

Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.